1. The Ex-Pharma Exec Leading Trump's COVID-19 Vaccine Program Has $10 Million in Stock Options for a Company Getting Federal Funding

    The Ex-Pharma Exec Leading Trump's COVID-19 Vaccine Program Has $10 Million in Stock Options for a Company Getting Federal Funding
    • Dr Moncef Slaoui, a former pharma executive, was announced last week as a lead figure in President Donald Trump's push for a coronavirus vaccine.
    • Slaoui resigned as a director of the company Moderna — which is trialing one vaccine — to take the position.
    • However, he continues to hold stock options worth more than $10 million in Moderna, which has seen its stock price skyrocket in recent months...
    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. Mr. President, I have very recently seen early data from a clinical trial with a coronavirus vaccine. And this data made me feel even more confident that we will be able to deliver a few hundred million doses of vaccine by the end of 2020.
  3. Topics Mentioned

  4. Authors